rs61751532
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001378213.1(BCL9L):c.4020G>A(p.Gln1340=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0737 in 1,613,746 control chromosomes in the GnomAD database, including 5,209 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.054 ( 338 hom., cov: 33)
Exomes 𝑓: 0.076 ( 4871 hom. )
Consequence
BCL9L
NM_001378213.1 synonymous
NM_001378213.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.29
Genes affected
BCL9L (HGNC:23688): (BCL9 like) Enables beta-catenin binding activity. Involved in several processes, including negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of epithelial to mesenchymal transition; and positive regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of beta-catenin-TCF complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 11-118898895-C-T is Benign according to our data. Variant chr11-118898895-C-T is described in ClinVar as [Benign]. Clinvar id is 402413.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.29 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0801 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCL9L | NM_001378213.1 | c.4020G>A | p.Gln1340= | synonymous_variant | 10/10 | ENST00000683865.1 | NP_001365142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCL9L | ENST00000683865.1 | c.4020G>A | p.Gln1340= | synonymous_variant | 10/10 | NM_001378213.1 | ENSP00000507778 | P4 | ||
BCL9L | ENST00000334801.7 | c.4020G>A | p.Gln1340= | synonymous_variant | 8/8 | 1 | ENSP00000335320 | P4 | ||
BCL9L | ENST00000526143.2 | c.3909G>A | p.Gln1303= | synonymous_variant | 8/8 | 5 | ENSP00000482938 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0542 AC: 8249AN: 152168Hom.: 338 Cov.: 33
GnomAD3 genomes
AF:
AC:
8249
AN:
152168
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0535 AC: 13430AN: 250948Hom.: 554 AF XY: 0.0529 AC XY: 7175AN XY: 135634
GnomAD3 exomes
AF:
AC:
13430
AN:
250948
Hom.:
AF XY:
AC XY:
7175
AN XY:
135634
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0758 AC: 110738AN: 1461460Hom.: 4871 Cov.: 65 AF XY: 0.0733 AC XY: 53265AN XY: 726996
GnomAD4 exome
AF:
AC:
110738
AN:
1461460
Hom.:
Cov.:
65
AF XY:
AC XY:
53265
AN XY:
726996
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0541 AC: 8245AN: 152286Hom.: 338 Cov.: 33 AF XY: 0.0530 AC XY: 3943AN XY: 74450
GnomAD4 genome
AF:
AC:
8245
AN:
152286
Hom.:
Cov.:
33
AF XY:
AC XY:
3943
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
33
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at